Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cancer Pain × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Sturge-Weber Syndrome 2 Seizures 2 Nausea 2 Vomiting 1 Parasomnias 1 Pain 1 Neoplasms 1 Marijuana Abuse 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Cancer Pain 1 Cachexia 1 Breast Neoplasms 1 Arthralgia 1 Appetitive Behavior 1 Anxiety Disorders 1

Interventions

Morphine 11 Oxycodone 8 Fentanyl 6 nabiximols 5 Methadone 4 Hydromorphone 4 Acetaminophen 3 Transcutaneous Electric Nerve Stimulation 2 Tapentadol 2 Naloxone 2 Lidocaine 2 Buprenorphine 2 Acupuncture Therapy 2 tanezumab 1 resiniferatoxin 1 oxycodone naloxone combination 1 fulranumab 1 cannabichromene 1 alvimopan 1 Water 1 Ultracet 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Therapeutic Touch 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡